Nivalin in the treatment of residual post-polio paralysis and pseudo-hypertrophic muscular dystrophy

Indian Pediatr. 1965 Mar;2(3):89-93.
No abstract available

MeSH terms

  • Child
  • Child, Preschool
  • Facial Paralysis / drug therapy*
  • Galantamine / adverse effects
  • Galantamine / therapeutic use*
  • Humans
  • Infant
  • Muscular Dystrophies / drug therapy*
  • Poliomyelitis / complications*

Substances

  • Galantamine